System Online

The Hybrid
Intelligence Platform.

A proprietary Hub-and-Spoke architecture combining secure local AI execution with cloud-synced mobile intelligence. Designed for the institutional biotech investor.

INITIAL RELEASE (v1.0)

Desktop Command Center

A comprehensive local interface ensures that executing agent logic and proprietary datasets remain secure offline, while giving analysts a high-throughput visualization layer for the AI Council's signals.

Desktop Lab Interface
LOCAL ENGINE

The Lab (Tkinter)

The central command center. Runs locally on secure hardware. Orchestrates the agent swarm, ingests raw SEC/FDA data, and executes proprietary valuation algorithms completely offline.

Air-gapped Execution
Python/Tkinter Core
SQLite Data Lake
Council Intelligence Dashboard
INTELLIGENCE DASHBOARD

Council Intelligence

The centralized screen where specialized AI agents present their synthesized findings. Features real-time tracking of catalyst events, institutional flow via Smart Money, and strategic options plays formulated by cross-agent consensus.

Multi-Agent Aggregation
Catalyst Tracking
Conviction Scoring

The AI Council

We don't rely on a single model. A swarm of specialized agents, each with a distinct persona and rigid specification, debate the investment thesis before human review.

23 Active Agents

Agent 001

THE DETECTIVE

Resolves complex corporate entity structures. Links obfuscated clinical trial sponsors to parent tickers using Wikidata and probabilistic matching.

Agent 006

THE STRATEGIST

Synthesizes inputs from all other agents. Calculates "Conviction Scores" and maps opportunities to specific proprietary playbooks (CSP vs Moonshot).

Agent 020

RISK ANALYST

Audits SEC 10-K filings for "Risk Factor" diffs. Flags silent changes in legal language that indicate undisclosed regulatory or IP threats.

Agent 009

VOLATILITY

Executes the "Cash-Secured Put" strategy. Scans option chains for high-IV opportunities backed by strong balance sheets and defined floors.

Proprietary Playbooks

CSP

Income Generation

STRATEGY: CASH_SECURED_PUT

Targeting high implied volatility around binary events. We identify "Floor Prices" based on Net Cash and Book Value, selling premium only when the strike is mathematically defended.

Moonshot

Asymmetric Upside

STRATEGY: MOONSHOT

Identifying Mispriced Optionality. Screening for Small Cap (<$500M) companies with Orphan Drug Designation and near-term catalysts where the market ignores the TAM.

Health

Capital Preservation

STRATEGY: FINANCIAL_HEALTH

"Cash is King". Survival analysis based on burn rates and cash equivalents. Ensuring companies have >18 months runway to withstand FDA delays without toxic dilution.

Value

Arbitrage

STRATEGY: DEEP_VALUE

Negative Enterprise Value. Identifying companies trading below their net liquidation value, effectively offering the clinical pipeline for free.